'Cardiac resynchronization therapy' presentation slideshows

Expanded Indications and Claims for Guidant CRT-D Devices

941 views • 65 slides

A Simplified Approach To ECHO Evaluation of CHF with Normal or Reduced EF

A Simplified Approach To ECHO Evaluation of CHF with Normal or Reduced EF. Anthony C. Pearson, MD, FACC 10/18/2008. Echo in CHF. Identifies Hypertrophic Cardiomyopathy and accurately measures LV Hypertrophy Excludes other causes of CHF or SOA Valvular disease (MR/MS, AS/AI)

1.26k views • 58 slides

Disclosures - None

282 views • 21 slides

Presenter Disclosure Information

Presenter Disclosure Information. William Hawkins Chairman and CEO, Medtronic Inc. FINANCIAL DISCLOSURE: Chairman and CEO, Medtronic Inc. UNLABELED/UNAPPROVED USES DISCLOSURE: N/A. Collaboration, Innovation and Restoring the Public Trust. Bill Hawkins Chairman and CEO, Medtronic

347 views • 14 slides

Optimizing parameters of a computational heart model to help develop improved pacing protocols in cardiac resynchronizat

384 views • 7 slides

Cardiac Rhythm Management Market: Global Industry Analysis

Around 30% of total death worldwide is caused by cardiovascular diseases, of which major part is accounted by heart diseases. The risk factors of heart disease includes elevated cholesterol levels, diabetes mellitus, cigarette smoking, obesity and hypertension. Frequency of these factors varies demographically, i.e. on the basis of geography, sex ratio and ethnicity. Ischaemic heart disease, is the leading type of heart disease, and causes 46% of cardiovascular deaths in men and 38% in women.

197 views • 6 slides

Global Electrophysiology Devices Market Growth Report 2017

Report provides the strategists, marketers and senior management with the critical information they need to assess.

35 views • 3 slides

Odds ratio (95%CI) for moderate or marked improvement in dyspnoea at 6,12 and 24 hours ( Likert )

0.1 1 10. Odds ratio (95%CI) for moderate or marked improvement in dyspnoea at 6,12 and 24 hours ( Likert ).

113 views • 2 slides